Delivery Order SPE2DB24D2101-SPE2DB25FKKGD
Award Date
5/6/25
Potential Completion Date
5/7/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of PROLIA 60 MG/ML SYRINGE to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 9, 2024 with a ceiling value of $10,460.52. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 10, 2024. There is no set-aside designation indicated. This appears to be a...
This federal contract award is for the delivery of PROLIA 60 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,743.42, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract type is Delivery Order, with a Firm Fixed Price pricing structure, and an ultimate completion date of September 20, 2024. This award is not associated with a...
This federal contract award is for the delivery of PROLIA 60 MG/ML syringes, awarded to the prime contractor AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The contract has a total ceiling value of $42,850.78 and runs through December 16, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award is for the delivery of Prolia 60 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, and has a ceiling value of $10,866.06. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It has an ultimate completion date of June 11, 2024. The contract does not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of PROLIA 60 MG/ML syringes. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,142.90 and an ultimate completion date of March 27, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order worth $34,232.81 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Firm Fixed Price contract, which has an ultimate completion date of December 20, 2024, is for the delivery of 4566771042 - PROLIA 60 MG/ML SYRINGEML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Prolia 60 mg/ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $2,652.47 and a ceiling value of $2,652.47. The ultimate completion date is February 6, 2024. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,733.97, is a Firm Fixed Price Delivery Order for the supply of PROLIA 60 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,264.23, is for the delivery of PROLIA 60 MG/ML SYRINGEML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 8, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,559.43, is for the delivery of 4566736887 PROLIA 60 MG/ML SYRINGEML. It is a Firm Fixed Price Delivery Order contract with a completion date of December 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...